-
Loading metrics
Clinical outcomes in non-small cell lung cancer patients with an ultra-high expression of programmed death ligand-1 treated using pembrolizumab as a first-line therapy: A retrospective multicenter cohort study in Japan
- Ryuya Edahiro,
- Masaki Kanazu,
- Hiroyuki Kurebe,
- Masahide Mori,
- Daichi Fujimoto,
- Yoshihiko Taniguchi,
- Hidekazu Suzuki,
- Katsuya Hirano,
- Toshihide Yokoyama,
- Mitsunori Morita
x
- Published: July 31, 2019
- https://doi.org/10.1371/journal.pone.0220570